Literature DB >> 11410884

Cyclin D1 overexpression associates with radiosensitivity in oral squamous cell carcinoma.

S Shintani1, M Mihara, Y Ueyama, T Matsumura, D T Wong.   

Abstract

Overexpression of cyclin D1, a G1 cell cycle regulator, is often found in many different tumor types, including oral squamous cell carcinomas (SCC). Recent laboratory experiments have demonstrated that cyclin D1 levels can influence radiosensitivity in various cell lines. This study evaluated the relationship between cyclin D1 expression levels and radiosensitivity in nine oral SCC cell lines (HSC2, HSC3, HSC4, SCC15, SCC25, SCC66, SCC111, Ca9-22, and NAN2) and 41 clinical patients with oral SCC who underwent preoperative radiation therapy. Radiosensitivity of the nine oral SCC cell lines differed greatly in their response to radiation, assessed by a standard colony formation assay. Likewise, the expression of cyclin D1 varied, and the magnitude of the cyclin D1 expression correlated with increased tumor radiosensitivity. The similar significant association between the response to preoperative radiation therapy and cyclin D1 overexpression was observed in the oral SCC patients who were treated with preoperative radiation therapy. These results suggest that cyclin D1 expression levels correlate to radiosensitivity and could be used to predict the effectiveness of radiation therapy on oral SCC. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410884     DOI: 10.1002/ijc.1014

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Targeting the RB-pathway in cancer therapy.

Authors:  Erik S Knudsen; Jean Y J Wang
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

2.  Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells.

Authors:  Andrew Fribley; Qinghua Zeng; Cun-Yu Wang
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

Review 3.  Proteomic identification of a direct role for cyclin d1 in DNA damage repair.

Authors:  Siwanon Jirawatnotai; Yiduo Hu; David M Livingston; Piotr Sicinski
Journal:  Cancer Res       Date:  2012-08-22       Impact factor: 12.701

Review 4.  Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases.

Authors:  Per Hydbring; Marcos Malumbres; Piotr Sicinski
Journal:  Nat Rev Mol Cell Biol       Date:  2016-04-01       Impact factor: 94.444

5.  Detection of clinically relevant copy number alterations in oral cancer progression using multiplexed droplet digital PCR.

Authors:  Curtis B Hughesman; X J David Lu; Kelly Y P Liu; Yuqi Zhu; Rebecca M Towle; Charles Haynes; Catherine F Poh
Journal:  Sci Rep       Date:  2017-09-19       Impact factor: 4.379

6.  Tumor expression of survivin, p53, cyclin D1, osteopontin and fibronectin in predicting the response to neo-adjuvant chemotherapy in children with advanced malignant peripheral nerve sheath tumor.

Authors:  Gabrielle Karpinsky; Malgorzata A Krawczyk; Ewa Izycka-Swieszewska; Aleksandra Fatyga; Agnieszka Budka; Walentyna Balwierz; Grazyna Sobol; Beata Zalewska-Szewczyk; Magdalena Rychlowska-Pruszynska; Teresa Klepacka; Bozenna Dembowska-Baginska; Bernarda Kazanowska; Anna Gabrych; Ewa Bien
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-13       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.